Researchers evaluated the real-world effectiveness of the 2025-2026 formulations of COVID-19 mRNA-1283 and BNT162b2 vaccines in US adults aged 65 years and older.
Fauci received his first COVID-19 vaccine in December 2020, around six months before his doctors discovered lung tissue death ...
The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a new study that we ...
The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including cancer, according to a new review published in The Lancet Tuesday.
Scientists at Wits University say that for Africa to achieve vaccine sovereignty, the continent must build and sustain its ...
WASHINGTON, DC: Jayanta Bhattacharya, Director of the National Institutes of Health. (Photo by Andrew Harnik/Getty Images) Director of the National Institutes of Health, Jay Bhattacharya, recently ...
Zacks Investment Research on MSN
MRNA Q2 earnings meet, stock down on norovirus vaccine setback
Moderna MRNA reported a second-quarter 2026 loss of $1.97 per share, in line with the Zacks Consensus Estimate. The loss ...
Elon Musk this week amplified an unfounded claim, based on a distortion of vaccine safety monitoring data, that COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results